In AML cells sensitive to Bcl-2 inhibition, venetoclax induced a rapid decrease of AMPK phosphorylation and activity, due to a caspase-dependent degradation of AMPK α, β, and γ subunits. Here, BCL2 is linked to acute myeloid leukemia.